Page last updated: 2024-11-06

cuprous sulfide

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth

Cross-References

ID SourceID
PubMed CID10130093
CHEBI ID51114
MeSH IDM0260757

Synonyms (13)

Synonym
cuprous sulfide
dicopper monosulfide
cuprasulfide
dicopper sulfide
CHEBI:51114
copper(1+) sulfide
kupfer(i)-sulfid
cuprous sulfide [mi]
1308-78-7
copper(i)sulfide
Q425127
copper sulfide (chalcocite)
SY061259

Research Excerpts

Compound-Compound Interactions

ExcerptReferenceRelevance
"The purpose of this report was to progress the advancement of nanotechnology combined with near-infrared (NIR) laser-mediated treatment for enhancing efficiency against breast cancer (MCF-7) cells."( Superficial synthesis of photoactive copper sulfide quantum dots loaded nano-graphene oxide sheets combined with near infrared (NIR) laser for enhanced photothermal therapy on breast cancer in nursing care management.
Wang, L; Yan, J, 2019
)
0.51

Dosage Studied

ExcerptRelevanceReference
" Furthermore, this combined therapy offers the possibility to lower the dosage of DOX in anticancer therapy, which would thus decrease the toxic effects on cancer patients."( Thermosensitive drug-loading system based on copper sulfide nanoparticles for combined photothermal therapy and chemotherapy in vivo.
Chen, H; Gu, Y; Gui, L; He, Y; Liang, L; Qu, S; Xu, Y; Yuan, Z; Zhou, X, 2018
)
0.48
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Drug Classes (1)

ClassDescription
copper sulfideCompounds with the general formula CuxSy.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Research

Studies (50)

TimeframeStudies, This Drug (%)All Drugs %
pre-19900 (0.00)18.7374
1990's1 (2.00)18.2507
2000's6 (12.00)29.6817
2010's37 (74.00)24.3611
2020's6 (12.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews1 (2.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other49 (98.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]